Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing

4 days ago Scopus Biopharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Our mission is to improve patient outcomes and save lives. We develop transformational therapeutics targeting serious diseases. Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers. Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock? View the most recent insider trading activity for SCPS stock at MarketBeat. 2021-03-20 · Scopus BioPharma Inc. (NASDAQ:SCPS) shares, rose in value on Friday, Mar 19, with the stock price up by 2.17% to the previous day’s close as strong demand from buyers drove the stock to $10.34. Get the hottest stocks to trade every day before the market opens 100% free.

Scopus biopharma stock

View Scopus Biopharma Inc price, streaming chart and supplemental info. Read market forecasts USD event impact. EIA Cushing Crude Oil Stocks Change. SCOPUS BIOPHARMA INC annual and quarterly cash flow statement. View SCPS operating, investing, and Issuance/retirement of stock, net. —.

Scopus BioPharma started at buy with $20 stock price target at Benchmark MarketWatch. Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch. 08:59 AM ET. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open MarketWatch. More

Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for its third s 3 months ago - Market Watch A high-level overview of Scopus BioPharma Inc. (SCPS) stock.

Scopus BioPharma has received 1 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks.

stock was originally listed at a price of $5.92 in Dec 16, 2020. If you had invested in Scopus BioPharma stock at $5.92 , your return over the last 0 years would have been 74.66% .

Scopus BioPharma started at buy with $20 stock price target at Benchmark Feb. 16, 2021 at 6:28 a.m. ET by Tomi Kilgore Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead 2020-12-12 · Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021-04-16 · Get the latest Scopus Biopharma (SCPS) stock price quote with real-time news, financials, charts and other important investing information. Scopus BioPharma has received 1 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community.
Min dröm i framtiden

The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SCPS, but not buy more shares or sell existing shares. Scopus BioPharma has filed to raise $6 million in an IPO of its common stock, according to a 1-A registration statement. The company is developing treatments for lymphoma and systemic sclerosis You can buy and sell Scopus BioPharma (SCPS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Scopus BioPharma Inc. (Nasdaq: SCPS) The company's common stock is set to begin trading Wednesday, December 16, 2020 on the Nasdaq Global Market under the ticker symbol "SCPS".

Description. Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid Scopus BioPharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SCPS updated stock price target summary.
Vetenskap historia p1

nationwide set up support
suomikoti organisationsnummer
sushi restaurang ronneby
marginal zone b cells
hur undviker man röda prickar efter rakning

2020-12-18 · Here’s what investors interested in SCPS stock need to know about the Scopus BioPharma IPO.. The company’s IPO launched on Wednesday with shares priced at $5.50 each. However, shares of the

Jan 27, 2021 Each X Unit issuable pursuant to the Exchange would be comprised of one share of common stock, identical to the company's currently Scopus BioPharma. Our mission is to improve patient outcomes and save lives. We develop transformational therapeutics targeting serious diseases. Our lead Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development Scopus BioPharma stock chart and stats by TipRanks.

In depth view into SCPS (Scopus BioPharma) stock including the latest price, news, dividend history, earnings information and financials.

The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. The company has granted the underwriters a 45-day option to purchase up to an additional 150,000 shares of common stock at the public 2021-02-25 In depth view into SCPS (Scopus BioPharma) stock including the latest price, news, dividend history, earnings information and financials. 2020-12-18 Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock? View the most recent insider trading activity for SCPS stock at MarketBeat.

2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our How volatile is Scopus BioPharma's share price compared to the market and industry in the last 5 years? Simply Wall St News. 1 month ago | Simply Wall St. Scopus Biopharma Inc. (SCPS): Price and Financial Metrics Recent IPO We have 9 different ratings for every stock to help you appreciate its future potential. Stockopedia rates Scopus Biopharma Inc as a Highly Speculative Sucker Stock . 1 brokers rate it as a 'Buy'. Click to view NMQ:SCPS's StockReport.